To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD

This study has been completed.

Study NCT00612456 Information provided by GlaxoSmithKline

First Received: January 29, 2008 Last Updated: March 15, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: February 5, 2010